Earnings History Data for CymaBay Therapeutics (CBAY) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
CymaBay Therapeutics
CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead product candidate, arhalofenate, is being developed for the treatment of gout. CymaBay Therapeutics Inc. is based in Newark, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-02-2024 | AH | CBAY | CymaBay Therapeutics | 3,661 | -0.35 | -0.32 | 0.00 | CymaBay Therapeutics GAAP EPS of -$0.35 misses by $0.04 [2/28/2024 4:55 PM] |
32.20 | -0.08 (-0.23%) |
32.29 | 0.02 (0.06%) |
7.26 - 32.33 | 7,177,513 | 4,180,000 | 1,798 | ||
| 07-11-2023 | AH | CBAY | CymaBay Therapeutics Inc. | 1,610 | -0.32 | -0.30 | -0.28 | CymaBay Therapeutics GAAP EPS of -$0.32 misses by $0.03 [11/7/2023 4:25 PM] |
15.66 | -0.78 (-4.71%) |
16.46 | 0.02 (0.12%) |
3.15 - 18.20 | 1,096,125 | 2,270,000 | 1,222 | ||
| 10-08-2023 | AH | CBAY | CymaBay Therapeutics Inc. | 1,210 | -0.01 | -0.21 | -0.31 | CymaBay Therapeutics GAAP EPS of -$0.01 beats by $0.22, revenue of $31.01M [8/10/2023 4:05 PM] |
13.45 | 0.49 (3.82%) |
12.95 | -0.01 (-0.08%) |
3.15 - 14.19 | 1,862,510 | 1,250,000 | 1,027 | ||
| 15-05-2023 | AH | 4:05 PM ET (May 15) |
CBAY | CymaBay Therapeutics Inc. | 1,000.00 | -0.29 | -0.16 | -0.32 | CymaBay Therapeutics GAAP EPS of -$0.29 misses by $0.19 [5/15/2023 4:07 PM] |
9.57 | -0.83 (-7.93%) |
10.10 | -0.30 (-2.88%) |
1.78 - 11.22 | 3,525,277 | 1,040,000 | 5,236 | |
| 16-03-2023 | AH | 4:05 PM ET (Mar 16) |
CBAY | CymaBay Therapeutics Inc. | 775.44 | -0.30 | -0.30 | -0.34 | CymaBay Therapeutics GAAP EPS of -$0.30 misses by $0.01 [3/16/2023 4:08 PM] |
9.61 | 0.46 (5.09%) |
9.04 | -0.10 (-1.09%) |
1.67 - 10.05 | 3,367,908 | 1,920,000 | 2,726 | |
| 14-11-2022 | AH | 4:05 PM ET (Nov 14) |
CBAY | CymaBay Therapeutics Inc. | 296.37 | -0.28 | -0.30 | -0.33 | CymaBay Therapeutics GAAP EPS of -$0.28 beats by $0.02 [11/14/2022 4:17 PM] |
3.68 | 0.07 (1.94%) |
3.51 | -0.10 (-2.77%) |
1.67 - 4.55 | 418,828 | 430,000 | 47,899 | |
| 11-08-2022 | AH | 4:05 PM ET (Aug 11) |
CBAY | CymaBay Therapeutics Inc. | 266.74 | -0.31 | -0.30 | -0.34 | CymaBay Therapeutics GAAP EPS of -$0.31 misses by $0.01 [8/11/2022 4:12 PM] |
4.04 | 0.30 (8.02%) |
3.90 | 0.16 (4.28%) |
1.67 - 4.74 | 438,919 | 770,000 | 2,957 | |
| 12-05-2022 | AH | 4:05 PM ET (May 12) |
CBAY | CymaBay Therapeutics Inc. | 158.35 | -0.32 | -0.31 | -0.25 | CymaBay Therapeutics GAAP EPS of -$0.32 misses by $0.01 [5/12/2022 4:17 PM] |
1.80 | 0.03 (1.40%) |
2.00 | 0.22 (12.36%) |
1.67 - 5.06 | 444,362 | 820,000 | 1,559 | |
|
||||||||||||||||||
| 17-03-2022 | AH | 4:05 PM ET (Mar 17) |
CBAY | CymaBay Therapeutics Inc. | 251.47 | -0.34 | -0.36 | -0.23 | CymaBay Therapeutics GAAP EPS of -$0.34 misses by $0.11 [3/17/2022 4:09 PM] |
3.17 | -0.01 (-0.31%) |
3.12 | -0.06 (-1.89%) |
2.67 - 5.13 | 1,089,791 | 417,308 | 10,177 | |
|
||||||||||||||||||
| 10-11-2021 | AH | 4:05 PM ET (Nov 10) |
CBAY | CymaBay Therapeutics Inc. | 302.90 | -0.33 | -0.29 | -0.17 | CymaBay Therapeutics EPS misses by $0.08 [11/10/2021 5:22 PM] |
4.32 | 0.04 (0.93%) |
4.50 | 0.22 (5.14%) |
3.39 - 8.48 | 445,043 | 370,000 | 13,059 | |
|
||||||||||||||||||
| 12-08-2021 | AH | 4:05 PM ET (Aug 12) |
CBAY | CymaBay Therapeutics Inc. | 263.56 | -0.34 | -0.27 | -0.16 | CymaBay Therapeutics EPS misses by $0.07 [8/12/2021 4:21 PM] |
3.62 | -0.34 (-8.59%) |
3.85 | -0.11 (-2.78%) |
3.56 - 9.06 | 607,817 | 430,000 | 684 | |
| 13-05-2021 | AH | 4:10 PM ET (May 13) |
CBAY | CymaBay Therapeutics Inc. | 295.79 | -0.25 | -0.24 | -0.19 | CymaBay Therapeutics EPS misses by $0.01 [5/13/2021 4:32 PM] |
4.30 | 0.18 (4.37%) |
4.01 | -0.10 (-2.55%) |
3.16 - 9.06 | 664,611 | 950,000 | 2,180 | |
|
||||||||||||||||||
| 25-03-2021 | AH | 4:05 PM ET (Mar 25) |
CBAY | CymaBay Therapeutics Inc. | 329.28 | -0.23 | -0.20 | -0.35 | CymaBay Therapeutics EPS misses by $0.03 [3/25/2021 4:13 PM] |
4.49 | -0.10 (-2.29%) |
4.65 | 0.06 (1.31%) |
1.38 - 9.06 | 841,157 | 840,000 | 5,491 | |
| 05-11-2020 | AH | 4:00 PM ET (Nov 5) |
CBAY | CymaBay Therapeutics Inc. | 573.83 | -0.17 | -0.17 | -0.38 | CymaBay Therapeutics EPS in-line [11/5/2020 4:27 PM] |
7.83 | -0.67 (-7.88%) |
8.50 | 0.0 (0.00%) |
1.21 - 9.06 | 1,180,174 | 926,128 | 61,412 | |
|
|
||||||||||||||||||
| 10-08-2020 | AH | 4:00 PM ET (Aug 10) |
CBAY | CymaBay Therapeutics Inc. | 394.70 | -0.16 | -0.23 | -0.35 | CymaBay Therapeutics EPS beats by $0.08 [8/10/2020 4:23 PM] |
6.03 | -0.87 (-12.61%) |
6.40 | -0.50 (-7.25%) |
1.21 - 7.09 | 2,666,678 | 9,793,502 | 95,048 | |
|
|
||||||||||||||||||